Aristotle University Of Thessaloniki (AUTH)
Μελέτη των μεταλλάξεων leiden και G20210A της προθρομβίνης σε διαβητικούς ασθενείς τύπου 2
Abstract
dc:descriptionType 2 diabetes mellitus is a heterogeneous disease, characterised by insulin resistance, impaired insulin secretion and increased glucose production. Several genes have been proposed to contribute to the pathogenesis of type 2 diabetes mellitus. Remarkably, associations found in a certain population were not confirmed in other populations, suggesting regional differences in the contribution of certain diabetes susceptibility genes or an artifactual effect. Objective: a) Whether there is an association between FVL and FIIG20210A mutations and type 2 diabetes mellitus in Greek patients and b) If these mutations are independent risk factors for the development of coronary artery disease (CAD), stroke or venous thrombosis (VT) in these patients. c) Ultrasound measurements to assess carotid atherosclerosis development in diabetic subjects with and without Leiden or G20210A prothrombin mutations. Research Design and Methods: Case control study. Cases: 362 patients suffering from type 2 diabetes mellitus. Group I (diabetic controls): Patients without thrombovascular complications (n= 270) and Group II: Patients with thrombovascular complications (n=92). Controls: 340 healthy persons. All the patients and controls were examined for FV Leiden and FII-G20210A mutations with PCR polymerase chain reaction. Ultrasonography analysis was used to measure carotid intima–media thickness (IMT) in 55 patients: 20 patients with normal genotype, 10 diabetics patients with FII-G20210A mutation, 23 with FV-Leiden mutation, and 2 patients carriers of both mutations. The diabetic patients on whom ultrasonography analysis was performed have the same risk factors for development of cardiovascular disease. The only difference was the presence or absence of FV Leiden and FΙΙG20210A mutations. Results: 14/340 controls (4.11%) carried the FVL and another 7 (2.06%) carried the FIIG20210A mutation. 36/362 diabetics (9.94%) carried the FVL mutation, while another 22 (6.07%) carried the FIIG20210A mutation and there was a statistically significant difference between cases and controls. From the diabetic population were excluded all the persons who had experienced a thrombotic event (group ΙΙ), there was no statistical difference in the prevalence of FVL and FIIG20210A mutations between group I and controls (for FVL: 7.4% vs 4.11%, p=0.078, and for FIIG20210A: 4.8% vs 2.06%, p=0.058). This difference shows that the association between T2DM and these mutations is more present in diabetic patients with thrombotic events than in diabetic patients without arterial or venous thrombosis. Four out of 29 diabetic patients with stroke carried the FIIG20210A mutation and the difference in the prevalence of this mutation between diabetics with stroke and diabetic controls is statistically significant (13.8% vs 4.8%, p=0.047) while in FVL there was a trend not reaching statistically significance concerning stroke (17.2% vs 7.4%, p=0.069). There was no association between FVL or FIIG20210A and CAD. In our study we found a very strong association between FVL (p<0.001) or FIIG20210A (p<0.017) mutations and venous thrombotic events in T2DM. Carotid ultrasound scans revealed that in diabetic patients carriers of FIIG20210A mutation the development of atherosclerotic plaque is greater than in subjects without the mutation, but it’s not statistically significant (p=0.258). Similarly in diabetics subjects carriers of FVL mutation. The development of atherosclerotic plaque is not greater than in subjects without the mutation (p=0.651). Conclusions: FVL and FIIG20210A mutations are increased in diabetics patients especially them with thrombotic complications, but it is not clearly known if they are related with the appearance of type 2 diabetes mellitus, while FIIG20210A mutation seems to predispose to stroke in patients suffering from type 2 diabetes mellitus. The development of atherosclerotic carotid plaque is not greater in diabetics subjects with or without the mutations. Also there was a very strong association between these thrombophillic mutations and venous thrombosis.
Degree
thesis:*- Grantor dc:publisher
- Aristotle University Of Thessaloniki (AUTH)
- Year dc:date
- 2008
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Frengidis, Theodoros
- Φρεγγίδης, Θεόδωρος
Subjects
dc:subject × 17Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/19574